Guido Ring
Internal Medicine · Cordele, GANPI 1174595904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $676 and has fallen 54.9% since, to $304 in 2022.
Across 91 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$324
- Abbott$273
- AbbVie$237
- Avanir Pharmaceuticals, Inc.$168
- AstraZeneca$149
- Amgen$74
- plus $393 from 14 others
What the payments were for
- Food & beverage$1,619100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $324 |
| Abbott | 6 | $273 |
| AbbVie(2 entities) | 13 | $237 |
| Avanir Pharmaceuticals, Inc. | 12 | $168 |
| AstraZeneca(2 entities) | 10 | $149 |
| Amgen | 5 | $74 |
| Novo Nordisk | 3 | $60 |
| Electromed, Inc. | 4 | $55 |
| Nestle Healthcare Nutrition Inc. | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Johnson & Johnson | 3 | $38 |
| Novartis | 2 | $36 |
| Vifor Pharma, Inc. | 1 | $21 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Fresenius USA Marketing, Inc. | 1 | $18 |
| Akebia Therapeutics Inc | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Medtronic | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre 2$139
- ELIQUIS$125
How this compares
$1,619 in reported general payments places this provider in the 70th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 20 | $5,243 |
| Duloxetine Hcl | 48 | $1,568 |
| Humalog Mix 75-25Insulin Lispro Protamin/Lispro | 13 | $1,126 |
| Diltiazem Hcl | 50 | $560 |
| Atorvastatin Calcium | 56 | $374 |
| Risperidone | 49 | $176 |
| Donepezil Hcl | 28 | $173 |
| Montelukast Sodium | 11 | $165 |
| Metoprolol Succinate | 13 | $38 |
| Hydrochlorothiazide | 14 | $37 |
| Lisinopril | 20 | $32 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Cordele
- David KavtaradzeCordele$19K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.